Infectious Disease Week in Review

From concerns of Guillain-Barré syndrome to the gut microbiota's effect on COVID-19 infection severity, these were the week's top stories.

From concerns of Guillain-Barré syndrome to the gut microbiota's effect on COVID-19 infection severity, these were the week's top stories.

Related Videos
Related Content

Do Cesarean-Section Babies Still Receive Essential Microbes?

March 10th 2023

Enterococci Enhances the Severity of Gastrointestinal Infections

March 8th 2023

Can Early Outpatient Treatment Reduce the Risk of Long COVID?

March 8th 2023

How the Gut Microbiome Drives HIV Reservoir Dynamics

March 6th 2023

How the Gut Microbiota Affects COVID-19 Vaccine Immunogenicity

March 2nd 2023

CDC Health Advisory: Increase in Highly Drug-Resistant Shigellosis

February 27th 2023

Do Cesarean-Section Babies Still Receive Essential Microbes?

March 10th 2023

Enterococci Enhances the Severity of Gastrointestinal Infections

March 8th 2023

Can Early Outpatient Treatment Reduce the Risk of Long COVID?

March 8th 2023

How the Gut Microbiome Drives HIV Reservoir Dynamics

March 6th 2023

How the Gut Microbiota Affects COVID-19 Vaccine Immunogenicity

March 2nd 2023

CDC Health Advisory: Increase in Highly Drug-Resistant Shigellosis

February 27th 2023

Do Cesarean-Section Babies Still Receive Essential Microbes?

March 10th 2023

Enterococci Enhances the Severity of Gastrointestinal Infections

March 8th 2023

Can Early Outpatient Treatment Reduce the Risk of Long COVID?

March 8th 2023

How the Gut Microbiome Drives HIV Reservoir Dynamics

March 6th 2023

How the Gut Microbiota Affects COVID-19 Vaccine Immunogenicity

March 2nd 2023

CDC Health Advisory: Increase in Highly Drug-Resistant Shigellosis

February 27th 2023
© 2023 MJH Life Sciences

All rights reserved.